KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax Provisions
Others
Ratios

Guardant Health (GH) Profit After Tax: 2017-2025

Historic Profit After Tax for Guardant Health (GH) over the last 8 years, with Sep 2025 value amounting to -$92.7 million.

  • Guardant Health's Profit After Tax rose 13.95% to -$92.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$398.8 million, marking a year-over-year increase of 22.17%. This contributed to the annual value of -$436.4 million for FY2024, which is 8.98% up from last year.
  • As of Q3 2025, Guardant Health's Profit After Tax stood at -$92.7 million, which was up 7.18% from -$99.9 million recorded in Q2 2025.
  • Over the past 5 years, Guardant Health's Profit After Tax peaked at -$72.3 million during Q4 2021, and registered a low of -$229.4 million during Q2 2022.
  • For the 3-year period, Guardant Health's Profit After Tax averaged around -$109.4 million, with its median value being -$102.6 million (2024).
  • As far as peak fluctuations go, Guardant Health's Profit After Tax plummeted by 237.30% in 2021, and later soared by 68.28% in 2023.
  • Guardant Health's Profit After Tax (Quarterly) stood at -$72.3 million in 2021, then crashed by 93.52% to -$139.9 million in 2022, then slumped by 33.67% to -$187.0 million in 2023, then skyrocketed by 40.65% to -$111.0 million in 2024, then climbed by 13.95% to -$92.7 million in 2025.
  • Its last three reported values are -$92.7 million in Q3 2025, -$99.9 million for Q2 2025, and -$95.2 million during Q1 2025.